Exact Sciences Announces Fourth-Quarter 2019 Results

Go back to Exact Sciences Announces Fourth-Quarter 2019 Results

Exact Sciences (EXAS) Tops Q4 Revenue View

February 11, 2020 4:12 PM EST

Exact Sciences (NASDAQ: EXAS) reported Q4 EPS of $0.56, which includes items and does not compare to the analyst estimate of ($0.35). Revenue for the quarter came in at $295.6 million versus the consensus estimate of $283.05 million.

"The Exact Sciences team delivered another strong... More